Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics

Journal of Vascular Surgery

Volumn 46, Issue 5, 2007, Pages 1026-1031

  Javerliat, Isabelle ^a   Goëau Brissonnière, Olivier ^a   Sivadon Tardy, Valérie ^b   Coggia, Marc ^a   Gaillard, Jean Louis ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; POLYESTER; RIFAMPICIN; TOBRAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; CHI SQUARE TEST; COLONY FORMING UNIT; CONTROLLED STUDY; DOG; FEMALE; GRAFT INFECTION; IMPLANTATION; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SAMPLING; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; AORTA, ABDOMINAL; BLOOD VESSEL PROSTHESIS; DOGS; FEMALE; GELATIN; MALE; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TOBRAMYCIN;

EID: 35548955954     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.06.023     Document Type: Article

References (39)

1. Seeger J.M., Petrus H.A., Welborn M.B., Ozaki C.K., Flynn T.C., and Huber T.S. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 32 (2000) 451-461
2. Mertens R.A., O'Hara P.J., Hertzer N.R., Krajewski L., and Beven E.G. Surgical management of infrainguinal arterial prosthetic graft infections: review of a 35-year experience. J Vasc Surg 21 (1995) 782-791
3. Sharp W.J., Hoballah J.J., Mohan C.R., Kresowik T.F., Martinasevic M., Chalmers R.T.A., et al. The management of the infected aortic prosthesis: a current decade of experience. J Vasc Surg 19 (1994) 844-850
4. Yeager R.A., Taylor L.M., Moneta G.L., Edwards J.M., Nicoloff A.D., McConnell, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg 30 (1999) 76-83
5. Jacobs M.J.H.M., Reul G.J., Gregoric I., and Cooley D.A. In situ replacement and extra-anatomic bypass for the treatment of infected abdominal aortic grafts. Eur J Vasc Endovasc Surg 5 (1991) 83-86
6. Robinson J.A., and Johansen K. Aortic sepsis: is there a role for in situ graft reconstruction. J Vasc Surg 13 (1991) 677-684
7. Young R.M., Cherry K.J., Davis P.M., Gloviczki P., Bower T.C., Panneton J.M., et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg 178 (1999) 136-140
8. Rutledge R., Baker V.V., Sherertz R., and Johnson G. Rifampin and cefazolin as prophylactic agents. Arch Surg 117 (1982) 1164-1165
9. Greco R.S., Harvey R.A., Smilow P.C., and Tesoriero J.V. Prevention of vascular prosthetic infection by a benzalkonium-oxacillin bonded polytetrafluoroethylene graft. Surg Gyn Obstet 155 (1982) 28-32
10. Sobinsky K.R., and Flanigan P. Antibiotic binding to polytetrafluoroethylene via glucosaminoglycan-keratin luminal coating. Surg 100 (1986) 629-633
11. Shenk J.S., Ney A.L., Tsukayama D.T., Olson M.E., and Bubrick M.P. Tobramycin-adhesive in preventing and treating PTFE vascular graft infections. J Surg Res 47 (1989) 487-492
12. Ney A.L., Kelly P.H., Tsukayama D.T., and Bubrick M.P. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection. J Trauma 30 (1990) 1000-1006
13. Haverich A., Hirt S., Karck M., Siclari F., and Wahlig H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J Vasc Surg 15 (1992) 187-193
14. Gahtan V., Esses G.E., Bandyk D.F., Nelson R.T., Dupont E., and Mills J. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts. J Surg Res 58 (1995) 105-110
15. Sago T., Mori Y., Takagi H., Iwata H., Murase K., Kawamura Y., et al. Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit. J Vasc Surg 37 (2003) 169-174
16. Darouiche R.O., and Mansouri M.D. In vitro activity and in vivo efficacy of antimicrobial-coated vascular grafts. Ann Vasc Surg 18 (2004) 497-501
17. Kinney E.V., Bandyk D.F., Seabrook G.A., Kelly H.M., and Towne J.B. Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 50 (1991) 430-435
18. Hernandez-Richter T., Schardey H.M., Löhlein F., Heiss M.M., Redondo-Müller M., Hammer C., et al. The prevention and treatment of vascular graft infection with a triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig. Eur J Vasc Endovasc Surg 20 (2000) 413-418
19. Ghiselli R., Giacometti A., Cirioni O., Mocchegiani F., Orlando F., Kamysz W., et al. Temporin A as a prophylactic agent against methicillin sodium susceptible and methicillin sodium resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg 36 (2002) 1027-1030
20. Ginalska G., Kowalczuk D., and Osinska M. A chemical method of gentamicin bonding to gelatine-sealed prosthetic vascular grafts. Int J Pharm 288 (2005) 131-140
21. Ginalska G., Osinska M., Uryniak A., Urbanik-Sypniewska T., Belcarz A., Rzeski W., et al. Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephtalate vascular prostheses. Eur J Vasc Endovasc Surg 29 (2005) 419-424
22. Sacar M., Scar S., Kaleli I., Onem G., Turgut H., Goksin I., et al. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J Surg Res 139 (2007) 170-175
23. Hardman S., Cope A., Swann A., Bell P.R.F., Naylor A.R., and Hayes P.D. An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts. Ann Vasc Surg 18 (2004) 308-313
24. Schmacht D., Armstrong P., Johnson B., Pierre K., Back M., Honeyman A., et al. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination. Vasc Endo Surg 39 (2005) 411-420
25. Ueberrueck T., Zippel R., Tautenhahn J., Gastinger I., Lippert H., and Wahlers T. Vascular graft infections: in vitro and in vivo investigations of a new vascular graft with long-term protection. J Biomed Mater Res B Appl Biomat 74 (2005) 601-607
26. Dell'Acqua G., Giacometti A., Cirioni O., Ghiselli R., Saba V., Scalise G., et al. Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis 190 (2004) 318-320
27. Hirose K., Marui A., Arai Y., Nomura T., Inoue S., Kaneda K., et al. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. J Vasc Surg 44 (2006) 377-382
28. th Annual Meeting of the Society for Biomaterials (1990), Society for Biomaterials, Charleston, South Carolina. Mt. Laurel, NJ May 20-23
29. Goëau-Brissonnière O., Leport C., Bacourt F., Lebrault C., Comte R., and Pechere J.C. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg 5 (1991) 408-412
30. Goëau-Brissonnière O., Mercier F., Nicolas M.H., Bacourt F., Coggia M., Lebrault C., et al. Treatment of vascular graft infection by in situ replacement with rifampin-bonded gelatine-sealed Dacron graft. J Vasc Surg 19 (1994) 739-744
31. Coggia M., Goëau-Brissonnière O., Leflon V., Nicolas-Chanoine M.H., and Péchère J.C. Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann Vasc Surg 15 (2001) 421-429
32. Javerliat I, Goëau-Brissonnière O, Bruneval P, Coggia M. Experimental study of a new vascular graft prebonded with antibiotic: healing, toxicity and antibiotic retention. Accepted in Ann Vasc Surg 2007.
33. Malassiney P., Goëau-Brissonnière O., Coggia M., and Pechère J.C. Rifampicin loading of vascular grafts. J Antimicrob Chemother 37 (1996) 1121-1129
34. Ricco J.B., and Intergard Silver Study Group. Intergard silver bifurcated graft: features and results of a multicenter clinical study. J Vasc Surg 44 (2006) 339-346
35. Goëau-Brissonnière O., Fabre D., Leflon-Guibout V., Di Centa I., Nicolas-Chanoine M.H., and Coggia M. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 35 (2002) 1260-1263
36. Hartmann G., Honikel K.O., Knüsel F., and Nüesch J. The specific inhibition of the DNA-directed RNA synthesis by rifampin. Biochim Biophys Acta 145 (1967) 843-844
37. Kunin C.M., Brandt D., and Wood H. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. J Infect Dis 119 (1969) 132-137
38. Mandell G.L., and Keit Vest T. Killing of intraleukocytic Staphylococcus aureus by rifampin: in vitro and in vivo studies. J Infect Dis 125 (1972) 486-490
39. Koshiko S., Sasajima T., Muraki S., Azuma N., Yamazaki K., Chiba K., et al. Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg 35 (2002) 779-785